Package 51662-1671-3

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51662-1671-3
Digits Only 5166216713
Product NDC 51662-1671
Product ID 51662-1671_3ba53405-5e73-c035-e063-6294a90ac0b1
Description

25 VIAL in 1 CARTON (51662-1671-3) / 1 mL in 1 VIAL (51662-1671-1)

Marketing

Marketing Status
Marketed Since 1986-09-24
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

NALOXONE HYDROCHLORIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "3ba53405-5e73-c035-e063-6294a90ac0b1", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["3ba53405-5e72-c035-e063-6294a90ac0b1"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (51662-1671-3)  / 1 mL in 1 VIAL (51662-1671-1)", "package_ndc": "51662-1671-3", "marketing_start_date": "19860924"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1671_3ba53405-5e73-c035-e063-6294a90ac0b1", "dosage_form": "INJECTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1671", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA070299", "marketing_category": "ANDA", "marketing_start_date": "19860924", "listing_expiration_date": "20261231"}